Skip to main content
Equibles

Philip H. Coelho

Board Member

Catalyst Pharmaceuticals, Inc.

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Philip H. Coelho

Philip H. Coelho is recorded as Board Member at Catalyst Pharmaceuticals, Inc.. Catalyst Pharmaceuticals, Inc. reported in an 8-K filed August 25, 2023 that Philip H. Coelho retired as independent member of the Board, effective August 22, 2023. Catalyst Pharmaceuticals, Inc. reported in an 8-K filed September 19, 2022 that Philip H. Coelho was appointed Director, effective September 19, 2022.

“Philip H. Coelho, an independent member of the Board, did not stand for re-election at the Annual Meeting.”
Catalyst Pharmaceuticals, Inc. Form 8-K, filed August 25, 2023 · Read the filing
“Patrick J. McEnany, Philip H. Coelho, Charles B. O’Keeffe, David S. Tierney, Donald A. Denkhaus, Richard J. Daly and Molly Harper were elected to the Company’s Board of Directors to serve until the 2023 Annual Meeting of Stockholders or until their successor is duly elected and qualified, or until their earlier death, resignation or removal.”
Catalyst Pharmaceuticals, Inc. Form 8-K, filed September 19, 2022 · Read the filing

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

  • Catalyst Pharmaceuticals, Inc.

    Board Member

    SEC 8-K

    Current

    2022-09-19–present

  • Catalyst Pharmaceuticals, Inc.

    Board Member

    Proxy statement

    2002-01-01–2023-08-22

Company network

Recorded roles and call appearances connecting this person to public companies.

Catalyst Pharmaceuticals, Inc.

Current role

Board Member

2002-01-01–present

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.